A promising new quasi-vaccine technology is to use anti-bodies from recovering covid-19 patients to provide vaccine-like protection. This technology is entering clinical trials. Effective supply is quite limited due to the need to acquire plasma from recovering patients: how to increase availabitity of COVID-19 convalescent plasma (CCP) and how best to allocate it is studied by Scott Kominers, Parag Pathak, Tayfun Sönmez, and Utku Ünver. This research is a fusion of medical science and social science and illustrates the benefits of collaboration.
The researchers’ proposed incentive based scheme to increase access to CCP therapy has had remarkable impact latey, as the US-based Covid Plasma Initiave decided to adopt the scheme.
CERGE-EI has developed a set of recommendations for safe re-opening. Although specifically oriented towards Czechia there are broader lessons here as well.
Miguel Poiares Maduro with a preliminary analysis of the Court’s judgement and its potential implications for the ECB and the EU’s financial assistance in mitigating the Covid-19 crisis.
Andrea Galeotti, Paolo Surico and Jakub Steiner clearly lay out the types and uses of testing and how it should be used to acquire crucial information and to provide necessary safety during reopening. An interview explaining this work is here, and a more technical and detailed version of there work is here.
Four imparatives for the African continent in order to combat the pandemic, outlined by Mehari Taddele Maru.
An article by Julian Jamison in the Washington Post warning of the consequences of locking down for low income countries.
Fabrizio Tassinari and Mehari Maru on why the EU needs to support Africa in its efforts to combat the pandemic.
Martin Scheinin offers best practice and problems drawing on the Finish experience.
Kalypso Nicolaïdis explains why and how in France-Culture.
In Bergamo apparently, although hard to believe that they shout in English.